CMS finalizes lower Medicare outpatient pay for 340B drugs at hospitals
Issue
On November 6, 2026, CMS published its final 2027 hospital outpatient rule, which pays the average sales price minus 28 percent for 340B drugs from January 1, 2027. Rural sole community, children’s and cancer hospitals are excepted.
The 340B remedy offset on other services rises from 0.5 to 2 percent. No health center is named in the 340B policy.
Sources for this story
Centers for Medicare & Medicaid Services — CY 2027 OPPS/ASC final rule with comment period CMS-1850-FC (Federal Register document 2026-22739, 91 FR 70284)Part of
Sources for your board packet
This story's source plus 4 related stories and their sources, ready to print for your team or board.
Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.
More in Funding & Budget
FQHC Talent. (2026, November 6). CMS finalizes lower Medicare outpatient pay for 340B drugs at hospitals. Source: Centers for Medicare & Medicaid Services — CY 2027 OPPS/ASC final rule with comment period CMS-1850-FC (Federal Register document 2026-22739, 91 FR 70284). Retrieved November 11, 2026, from https://www.fqhctalent.com/intel/cms-cy2027-opps-final-rule-340b-drugs-asp-minus-28-november-2026